Pharmena S.A. (WSE:PHR)
Poland flag Poland · Delayed Price · Currency is PLN
3.300
-0.130 (-3.79%)
Mar 17, 2026, 5:00 PM CET

Pharmena Revenue

In the year 2025, Pharmena had annual revenue of 1.58M PLN with 488.43% growth. Pharmena had revenue of 391.00K in the quarter ending December 31, 2025, with 344.32% growth.

Revenue
1.58M
Revenue Growth
+488.43%
P/S Ratio
24.22
Revenue / Employee
225.29K
Employees
7
Market Cap
38.20M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.58M1.31M488.43%
Dec 31, 2024268.00K-31.00K-10.37%
Dec 31, 2023299.00K--
Dec 31, 2022299.00K-14.91M-98.03%
Dec 31, 202115.21M5.28M53.16%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BIOTON282.52M
Ryvu Therapeutics90.41M
Synthaverse71.76M
Mabion14.81M
Captor Therapeutics Spolka Akcyjna7.57M
Molecure5.86M
Urteste1.80M
Poltreg250.00K
Revenue Rankings